Operating Lease, Liability in USD of Unicycive Therapeutics, Inc. from Q1 2023 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Unicycive Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q1 2023 to Q3 2025.
Unicycive Therapeutics, Inc. Operating Lease, Liability for the quarter ending September 30, 2025 was $265K, a 67.2% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Unicycive Therapeutics, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$265K	-$542K	-67.2%	Sep 30, 2025	10-Q	2025-11-12
Q2 2025	$409K	-$225K	-35.5%	Jun 30, 2025	10-Q	2025-08-14
Q1 2025	$548K	-$167K	-23.4%	Mar 31, 2025	10-Q	2025-05-14
Q4 2024	$681K	-$112K	-14.1%	Dec 31, 2024	10-K	2025-03-31
Q3 2024	$807K			Sep 30, 2024	10-Q	2024-11-13
Q2 2024	$634K			Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$715K	-$285K	-28.5%	Mar 31, 2024	10-Q	2024-05-13
Q4 2023	$793K			Dec 31, 2023	10-K	2024-03-28
Q1 2023	$1M			Mar 15, 2023	10-K	2024-03-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.